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is a competent vector for Rift Valley fever 
phlebovirus in Europe
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Abstract 
Background: Aedes vexans (Meigen) is considered a nuisance species in central Europe and the Mediterranean 
region. It is an anthropophilic and mammalophilic floodwater mosquito involved in the transmission of several 
arboviruses. Rift Valley fever (RVF) is a relevant mosquito-borne zoonosis, affecting mainly humans and ruminants, that 
causes severe impact in public health and economic loses. Due to globalization and climate change, the European 
continent is threatened by its introduction. The main purpose of the present study was to evaluate the vector compe-
tence of a European field-collected Ae. vexans population.
Methods: Aedes vexans field-collected larvae were reared in the laboratory under field-simulated conditions. To 
assess the vector competence for Rift Valley fever phlebovirus (RVFV) transmission, adult F0 females were exposed to 
infectious blood meals containing the 56/74 RVFV strain. Additionally, intrathoracic inoculations with the same virus 
strain were performed to evaluate the relevance of the salivary gland barriers. Natural circulation of alphavirus, flavivi-
rus and phlebovirus was also tested.
Results: To our knowledge, an autochthonous Ae. vexans population was experimentally confirmed as a competent 
vector for RVFV for the first time. This virus was capable of infecting and disseminating within the studied Ae. vexans 
mosquitoes. Moreover, infectious virus was isolated from the saliva of disseminated specimens, showing their capacity 
to transmit the virus. Additionally, a natural infection with a circulating Mosquito flavivirus was detected. The co-infec-
tion with the Mosquito flavivirus seemed to modulate RVFV infection susceptibility in field-collected Ae. vexans, but 
further studies are needed to confirm its potential interference in RVFV transmission.
Conclusions: Our results show that field-collected European Ae. vexans would be able to transmit RVFV in case of 
introduction into the continent. This should be taken into consideration in the design of surveillance and control 
programmes.
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Background
Aedes vexans (Meigen, 1830) is a floodwater mosquito 
widely distributed throughout the Holarctic region 
and it is native in eastern Europe. This species inhabits 
a variety of habitats, especially within rural areas [1]. It 
mostly breeds in floodplains, rivers and lakes. As most 
floodwater mosquitoes, Ae. vexans lay their eggs near 
temporary or semi-permanent ground pools predis-
posed to seasonal inundations. Their eggs in diapause 
survive long periods of drought and hatch massively after 
flooding episodes. Aedes vexans is able to complete its 
developmental cycle in only a few days producing high 
population densities [2]. Adult females are aggressive 
bitters with low host specificity among mammals and 
humans [3], relevant for potential pathogen transmission. 
In North America and Europe, several arboviruses, such 
as West Nile virus (WNV), Snowshoe hare virus (SSHV), 
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Jamestone Canyon virus (JCV) [4], Tahyna virus (TAHV) 
[5], and Batai virus (BATV) [6] to name a few, have been 
isolated from Ae. vexans. In Africa, Ae. vexans is con-
sidered one of the primary vectors of Rift Valley fever 
phlebovirus (RVFV) [7, 8], and has been found naturally 
infected with the virus [9]. In addition, its competence 
in the transmission of RVFV has been confirmed exper-
imentally in field populations from Africa and the USA 
[9–11].
Rift Valley fever (RVF) is a zoonotic vector-borne viral 
disease that mainly affects domesticated ruminants and 
humans. Rift Valley fever is responsible for high mortality 
rates in newborn and juvenile ruminants, and abortions 
in pregnant animals [12]. Human infections may vary 
from an asymptomatic to mild febrile illness, but 1% of 
them may develop into severe encephalitis, haemorrhagic 
fever and death [13]. Its causal agent, RVFV, belongs to 
the genus Phlebovirus within the family Phenuiviridae. 
Unlike most phleboviruses, which are primarily transmit-
ted by sand flies, RVFV is transmitted predominantly by 
infected mosquito bites [11].
Due to its dreadful impacts on public health and the 
economy in endemic countries, RVFV belongs to the 
World Organization for Animal Health (OIE)’s list of 
notifiable animal diseases of concern, and is classified 
as a category A priority pathogen by the National Insti-
tute of Allergy and Infectious Diseases (NIAID) [14]. In 
the last decades, RVFV distribution has expanded from 
its original location in sub-Saharan Africa to North and 
West Africa, the Arabian Peninsula, Mayotte Island and 
Madagascar [9, 12, 13, 15]. Although no RVF cases have 
been reported in Europe so far, globalization and climate 
change have raised concerns of its introduction through 
the Mediterranean basin. While predictive risk models of 
the introduction of RVF within the European Union have 
reported a low risk [12], a study using a spatial multicri-
teria decision-making (MCDM) model for RVF outbreak 
occurrence in Spain, showed a high suitability for RVF in 
the east-coast regions [16], where Ae. vexans mosquito is 
present.
For a better understanding of the potential role in the 
transmission of RVFV of an autochthonous population of 
Ae. vexans in Europe, we tested the ability of field-cap-
tured Ae. vexans mosquitoes from Begues municipality 
in Catalonia (Spain) for the transmission of RVFV.
Methods
Sample collection and mosquito rearing
In September 2016 and May 2019, after heavy rain epi-
sodes, Ae. vexans third- and fourth-instar larvae were 
collected from Begues municipality (41°19′57.94″N, 
1°54′20.40″E) (Catalonia, Spain). To obtain an F0 gen-
eration, larvae were reared in the laboratory under local 
field-simulated conditions (photoperiod 14 h day:10 h 
night, relative humidity: 80%, temperature: 22–26  °C) 
using the same water and substrate from their original 
breeding site. Specimen identification was based on mor-
phology as described by Schaffner et al. [17].
Virus strain and inoculum preparation
A South African virulent 56/74 RVFV strain (viral stock 
provided by Alejandro Brun, INIA), isolated from cattle 
in 1974 [18] was used. The virus was passaged twice in 
Aedes albopictus clone C6/36 cells and titrated in Afri-
can green monkey kidney (Vero) cells (both cell lines 
provided by Joan Pujols, IRTA-CReSA, Barcelona, Spain) 
to obtain a 50% tissue culture infective dose per millili-
tre  (TCID50/ml) [19]. For mosquito blood meals, fresh 
heparinized bovine blood (Servei de granja i camps 
experimentals (SGICE), Veterinary Faculty, Autono-
mous University of Barcelona) was supplemented with 
adenosine 5’-triphosphate (ATP) disodium salt hydrate 
(5 × 10−3 M) (Sigma-Aldrich, St. Louis, MO, USA) as 
phagostimulant. Infectious blood meals were prepared 
by mixing (1:3) bovine blood and virus to obtain a final 
concentration of 7.5  log10  TCID50/ml. The viral dose 
employed in our assay was similar to those detected pre-
viously in blood samples from experimentally infected 
European lambs [19].
Design of the vector competence assay
The competence for the transmission of RVFV of a Euro-
pean field-captured Ae. vexans population was assessed 
in two different years, 2016 and 2019. In 2016, at the 
Institut de Recerca i Tecnologies Agroalimentaries – 
Centre de Recerca en Sanitat Animal (IRTA – CReSA) 
Biosafety Level 3 (BSL3) facilities, 422 non-blood-fed F0 
females aged 7–9 days were exposed to artificial feed-
ings. All F0 females were starved for 24 h and exposed 
to an infectious blood meal that was performed using a 
Hemotek feeding system (Discovery Workshop, Accring-
ton, UK) set at 37.5 °C for one hour. A specific pathogen-
free (SPF) chicken skin served as a feeding membrane. 
Simultaneously, a virus-free blood meal was offered to 
one group to obtain a negative control. After feedings, 
specimens were anesthetized by exposing them to carbon 
dioxide  (CO2); fully engorged females (FEF) were sepa-
rated and kept in individual cardboard cages (Watkins 
& Doncaster, Leominster, UK) under rearing conditions 
(photoperiod 14 h day:10 h night, relative humidity: 80%, 
temperature: 22–26 °C). On the same day of feeding, 
three FEF from each group were sacrificed to verify the 
presence or absence of the virus. The remaining unfed 
females were maintained deprived of sucrose for another 
24 h and subjected to a second feeding (following 48 h of 
starvation). The same procedure for feeding and female 
Page 3 of 8Birnberg et al. Parasites Vectors          (2019) 12:484 
classification were performed, with the only difference to 
verify the infectious status, five FEF were sacrificed per 
group. Twenty-one (17 exposed to RVFV and four from 
the negative control) and 40 FEF (35 exposed to RVFV 
and five from the negative control), from the first and 
second feeding, respectively, were maintained for 14 
days under rearing conditions until the completion of the 
extrinsic incubation period (EIP).
At 14 dpe, all specimens were anesthetized with  CO2. 
Legs and wings were removed from the body of each 
specimen and stored in 1.5 ml tubes containing 0.5 ml 
Dulbecco’s modified Eagle’s medium (DMEM) (Lonza, 
Basel, Switzerland). Immediately after dissection, saliva 
samples were collected by the capillary technique used by 
Brustolin et  al. [20]. All samples were stored at − 80  °C 
until processed. Specimens from the negative control 
group helped to verify the survival of the studied indi-
viduals and their infection status until the end of the 
experiment.
In 2019, 229 F0 females were obtained from field-col-
lected larvae. Prior artificial feeding, 148 7–9 day-old 
non-blood-fed females were deprived of sucrose for 48 h 
to ensure a higher feeding rate. Artificial feeding, speci-
men maintenance, sample collection and processing were 
performed as described above for the previous assay.
Since the number of disseminated specimens after 
oral exposure to RVFV was low, to better evaluate the 
transmission rate of this mosquito population, as well 
as, to assess the relevance of the salivary glands barriers, 
intrathoracic inoculations were performed.
RVFV intrathoracic inoculation in mosquitoes
Using a XenoWorks analog microinjector (BRI) (Sutter 
Instrument, CA, USA), 67 9–12 day-old females, from 
the same 2019 batch, were inoculated with 1–2 µl of the 
same RVFV strain (5.67  log10  TCID50) previously used in 
artificial feeding assays. Fourteen specimens were inocu-
lated with sterile PBS as an inoculation and survival con-
trol. To confirm the infection status, five specimens were 
sacrificed the same day of microinjection. Inoculated 
specimens were maintained individually for 7 days under 
previous rearing conditions. At day 7 post-inoculation 
(7 dpi) all specimens were anesthetized with  CO2, legs 
and wings were detached from the body, and the saliva 
of all females harvested as previously described for arti-
ficial feeding. Bodies, legs and wings, and saliva samples 
were stored at − 80 °C until molecular analysis could be 
completed.
Detection and isolation of RVFV
Viral RNA was extracted from bodies, legs and wings, 
and saliva samples using NucleoSpin® RNA Virus kit 
(Macherey-Nagel, Düren, Germany). RVFV detection 
and quantification were performed following the proto-
col previously described [20] where the limit of detection 
was established at 0.09  TCID50 per reaction. Quantifica-
tion cycle (Cq) values below 36 were considered posi-
tive for RVFV. Saliva samples were also incubated in 
Vero cells (37 °C, 5%  CO2) for RVFV isolation for 7 days, 
before cytopathic effect was visually evaluated.
Parameters to evaluate Ae. vexans vector competence 
for RVFV
At 14 dpe, infection, disseminated infection and trans-
mission rates (IR, DIR and TR, respectively), and trans-
mission efficiency (TE) were estimated. IR corresponds 
to the fraction of FEF whose bodies tested positive for 
RVFV. DIR is the proportion of FEF with RVFV infection 
in legs and wings among FEF with infected bodies. TR is 
the proportion of FEF with RVFV positive saliva among 
FEF with disseminated infection [20]. TE is the percent-
age of FEF with infectious saliva among all the FEF [21].
Alphavirus, flavivirus and phlebovirus detection
As previous studies revealed arboviral circulation in the 
study area [22], female mosquitoes, which were subjected 
to artificial blood meals and intrathoracic inoculations, 
were screened by reverse transcription nested polymer-
ase chain reactions (RT-nPCR) to detect phlebovirus 
(family Phenuiviridae) [23], flavivirus (family Flaviviri-
dae) [24] and alphavirus (family Togaviridae) [25] natu-
ral infections. Amplified flavivirus NS5 gene fragments 
were purified, sequenced and submitted to a basic local 
alignment search tool (BLAST) query for taxonomic 
assignation. To discard a virus insertion in the mosquito 
genome, DNA extracts from the samples that tested 
positive for flavivirus were treated with Ribonuclease 
A (RNase A) (Sigma-Aldrich, St. Louis, MO, USA) [26] 
prior flavivirus PCR amplification.
Statistics
In order to assess whether the natural infection of the 
Mosquito flavivirus influenced the vector competence for 
RVFV, the proportions of RVFV-infected mosquitoes in 
both Mosquito flavivirus-positive and Mosquito flavivirus-
negative groups were compared using the Fisherʼs exact 
test [27]. Furthermore, we evaluated the differences in the 
mean RVFV Cq values of infected specimens depending 
on the presence/absence of the Mosquito flavivirus with 
a Wilcoxon test. All statistical analyses were carried out 
using R statistical software (http://cran.r-proje ct.org/).
Results
Aedes vexans feeding and mortality rates
Four hundred and twenty-two and 148 Ae. vexans females 
emerged from field-collected larvae in 2016 and 2019, 
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respectively. Low feeding rates (FR) were obtained after 
artificial blood meals [FR1 = 6.4% (27/422); FR2 = 12.6% 
(50/395); FR3 = 19.6% (29/148)].
In 2016, a mortality rate of 3.9% (3/77) was observed 
after blood-feeding; two and one deceased specimens 
exposed to RVFV and negative control groups, respec-
tively. Meanwhile, in 2019 the mortality rates observed 
were 13.8% (4/29) and 21% (17/81) in females, which 
were orally exposed to RVFV and females subjected to 
intrathoracic inoculations, respectively.
Flavivirus detection in the field‑collected Aedes vexans 
population
In 2016, flavivirus RT-nPCR showed a 58.4% (45/77) nat-
ural infection with a Mosquito flavivirus (71-nucleotide 
fragment; 99% similarity with OcFV137A_09, GenBank: 
JN257977.1). A similar prevalence of the Mosquito flavi-
virus (53.9%; 48/89) was observed for this mosquito pop-
ulation in 2019. Ribonuclease A (RNase A)-treated DNA 
extracts were negative for flavivirus by RT-nPCR discard-
ing viral genome insertions. Alphavirus and phlebovirus 
screening excluded natural infection in the studied Ae. 
vexans population.
Vector competence of Aedes vexans for Rift Valley fever 
phlebovirus after oral exposure
Vector competence estimators evidenced that the 
RVFV infectious dose used in the present study (7.5 
 log10  TCID50/ml in infectious blood) allowed the virus 
to infect the body, disseminate through the haemo-
lymph and be transmitted by field-captured Ae. vex-
ans mosquitoes (Tables 1, 2). Only 17.7% (8/45) of the 
mosquitoes naturally infected with flavivirus resulted 
in infection with RVFV in contrast to 30% (6/20) of 
non-flavivirus-infected mosquitoes (Table 1). However, 
given the small sample size, differences were not sig-
nificant (P = 0.33). Additionally, no difference (P = 1) in 
the mean RVFV Cq values of infected specimens was 
observed between groups, with and without Mosquito 
flavivirus (Fig. 1).
Out of six specimens with disseminated infection, five 
tested positive for RVFV in saliva (TR of 83.3%) by RT-
qPCR (Cq values: 22.38–33.94). The viability of RVFV 
viral particles of all these samples was confirmed by the 
cytopathic effect observed after incubation on Vero cell 
monolayers. Of the females which were able to transmit 
RVFV, three belonged to the Mosquito flavivirus natu-
rally infected group; and two, to the non-infected group. 
For this Ae. vexans population, a transmission efficiency 
(TE) of 7.7% (5/65) was estimated.
Evaluation of salivary gland barriers of Aedes vexans 
for Rift Valley fever phlebovirus after intrathoracic 
inoculation
At day seven post-inoculation (7 dpi), RVFV dissemi-
nation and infection in all the specimens subjected to 
intrathoracic inoculations were confirmed (DIR = 100%, 
45/45 and IR = 100%, 45/45). All the saliva samples 
that tested positive for RVFV by RT-qPCR (37/45; 
Cq = 23.89–33.34) also showed cytopathic effect after 
incubation on Vero cell monolayers. An 82.2% transmis-
sion rate was estimated, out of 45 inoculated specimens, 
37 were able to transmit the virus.
Discussion
To our knowledge, the present study reports for the first 
time a European field population of Ae. vexans as a com-
petent vector for RVFV. In our study, oral exposure to the 
virulent strain RVFV 56/74 (7.5  log10  TCID50/ml in infec-
tious blood) denoted severe and moderate importance 
of the Ae. vexans midgut infection and escape barriers, 
respectively; the virus was unable to cross these barri-
ers in 78.5% and 51.1% in the overall FEF in each case. 
Meanwhile, the salivary gland barriers seem to be less 
important when a disseminated infection has already 
occurred. In the present study, transmission rates after 
oral exposure to the virus (83.3%) and after intrathoracic 
microinjections (82.2%) indicate that once RVFV is circu-
lating through the haemocoel it is capable of successfully 
infecting the salivary glands and can transmit through 
the mosquito saliva.
Our overall results suggest that the studied population 
of Ae. vexans exhibits a low vector competence for RVFV 
(TE of 7.7%). Similarly, a German Ae. vexans laboratory 
colony was categorized as a low competent vector when 
orally exposed to infectious blood meals containing the 
virulent ZH548 strain and the avirulent Clone 13 strain 
[28]. Previous studies have shown that Ae. vexans infec-
tion susceptibility and vector competence for RVFV is 
heterogeneous among geographically separated popula-
tions. In Senegal, for example, F1 specimens exposed to 
infectious blood meals containing three African strains 
(ArD141967, AnD133719 and SHM172805: at 4.5–
9.5 × 106 PFU), exhibited moderate significance of the 
MIB, MEB and salivary gland barriers (IR: 30–85%; DR: 
10.5–37%; and TR: 13–33.3%) [9]. These results were in 
accordance with several studies conducted at the USA 
where field captured specimens were subjected to oral 
exposure to viraemic animals inoculated with a vari-
ety of ZH501 strain doses  (104.1–10.2PFU/ml) [10, 11]. In 
all cases, Senegalese and USA Ae. vexans populations 
showed a moderate RVFV vector competence. In con-
trast, studies that included populations from Canada 
[29], California and Colorado [30], where field Ae. vexans 
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populations were exposed to highly viraemic animals, 
revealed an inability to disseminate and transmit RVFV, 
respectively. Divergent results, besides the mosquito pop-
ulations, could also be explained by differences in the viral 
strains or the infection methodologies used in each case.
The finding that the autochthonous population of Ae. 
vexans studied was naturally infected with a field-circu-
lating Mosquito flavivirus, and it was maintained in the 
field through the years, was an interesting outcome of the 
experiment. The prevalence of this Mosquito flavivirus 
was consistent in both sampling years. Regarding RVFV 
co-infection with the circulating Mosquito flavivirus, our 
results show that the presence of the Mosquito flavivirus 
seemed to decrease the susceptibility to RVFV infection, 
although this effect was not statistically significant. Con-
trasting results were observed in our previous study [31]. 
The vector competence of a Culex pipiens colony, which 
was previously infected intrathoracically with Culex Fla-
vivirus (CxFV), for the same RVFV strain (RVFV 56/74) 
was not affected by the infection with the CxFV. Diverse 
outcomes have been observed in several co-infection 
studies involving an insect-specific virus and a patho-
genic one. For instance, in Colorado, Cx. pipiens natu-
rally infected with CxFV showed a possible suppression 
in West Nile virus (WNV) early infection [32]. A similar 
co-infection, in Culex quinquefasciatus from Honduras, 
had the opposite effect, an enhancement of WNV trans-
mission [33]. Aedes triseriatus turned out to be resistant 
to Snowshoe hare virus infection in presence of LaCrosse 
virus, a closely related bunyavirus [34]. Further studies 
are required to clarify the potential role of the Mosquito 
flavivirus in the infection susceptibility and transmission 
of RVFV in the Ae. vexans population studied.
Finally, the experimental confirmation of a European 
biting nuisance species, such as Ae. vexans, as a RVFV 
vector highlights the necessity of regular and exhaus-
tive arboviral vector surveillance and control strategies 
in susceptible areas in the Mediterranean region, where 
Ae. vexans is distributed, to avoid a possible outbreak 
in the case of RVFV introduction.
Conclusions
The present study demonstrates for the first time that 
a European field-collected population of Ae. vexans 
may be involved in the transmission of RVFV in case 
Table 2 Relevance of the midgut and salivary glands barriers in Aedes vexans after oral exposure to RVFV 56/74
a Uncertain given the small sample size
Notes: Rating of relative importance of the barrier: null, virus crosses this barrier in >80% of females; +, minor, virus crosses this barrier in 60–80% of females; ++, 
moderate, virus crosses this barrier in 40–60% of females; +++, severe, virus crosses this barrier in 20–40% of females; ++++, very severe, virus crosses this barrier in 
< 20% of females [10]
Abbreviations: IR, infection rate; DIR, disseminated infection rate; TR, transmission rate; TE, transmission efficiency; MIB, midgut infection barrier; MEB, midgut escape 
barrier; SB, salivary gland barrier
IR
MIB
DIR
MEB
TR
SB
TE Overall vector competence
Relative importance (%) 14/65 (21.5) +++ 6/14 (42.9) ++ 5/6 (83.3)  nulla 5/65 (7.7) Low
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were not influenced by the Mosquito flavivirus infection
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of introduction to the continent. This knowledge con-
tributes to the development of more accurate strategies 
for vector surveillance and control of RVF. The natu-
rally circulating Mosquito flavivirus seems to modu-
late the susceptibility to RVFV infection in the assessed 
population of Ae. vexans. Further studies are needed to 
elucidate the potential of insect-specific viruses for the 
development of new biotools for the control of sanitary 
relevant arboviruses and their vectors.
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